U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911423) titled 'Immunotherapy in Neuroendocrine Carcinoma of the Cervix' on Oct. 10.
Brief Summary: This retrospective study reviews existing medical records. No new treatments or tests are given. The study asks how well immunotherapy worked for people with a rare cancer called neuroendocrine carcinoma of the cervix. Immunotherapy is a treatment that helps the body's immune system fight cancer. The investigators will review the records of approximately 150 participants treated with immunotherapy for this cancer. The study will evaluate: (1) how long participants lived without the cancer getting worse; (2) how long participants lived overall; (3) whe...